N, S., S, S., M, R., & A, R. (2019). Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats. Dove Medical Press.
Cita Chicago Style (17a ed.)N, Samsu, Soeharto S, Rifai M, y Rudijanto A. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.
Cita MLA (8a ed.)N, Samsu, et al. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.